Gastro Medical News about endocrine tumor

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The outcomes after surgical resection in pancreatic endocrine tumors: An institutional experience
European Journal of Surgical Oncology, 06/04/09

You DD et al. – Study demonstrates that surgical resection is curative for well-differentiated tumors (WDT) and recurrences are frequent in spite of curative resection for malignant pancreatic endocrine tumors (PET).

Methods

Aim was to analyze surgical outcomes of sporadic PET and factors influencing survival
Between 1995 and 2007, pts who underwent surgery were retrospectively reviewed for clinicopathologic variables and outcomes according to the WHO classifications

Results

Total 96 pts:
- 39 pts had WDT with benign behavior
- 23 had uncertain behavior
- 27 had low-grade carcinoma, and
- 7 were diagnosed with high-grade carcinoma
R0 resection was performed in 84 pts
No recurrence was observed in WDT regardless of its behavior or curability
However, 16/34 pts with carcinoma had recurrence
5 yr OS for R0-resected pts with carcinoma was 57%
OS at 3 yrs for R1/R2-resected pts was 23%
WHO classification and R0 resection were independent prognostic factors in multivariate analysis